Join Medical Chronicle for a free, one-hour, CPD-accredited webinar on Multiple myeloma and the role of lenalidomide. This webinar is sponsored by Adcock and presented by Dr David Brittain.
Date: 13 February 2025
Time: 7PM
Presenter: Dr David Brittain
More about our speaker:
Dr David Brittain graduated his MB ChB in 1988 from the University of the Witwatersrand. He specialised in Haematopathology (1996) and super specialised in Clinical Haematology (1998) from the same university. After running his own private practice in Johannesburg from 2000 - 2008 he joined the Alberts, Bouwer & Jordaan practice where he has worked as a Director in the Haematology and Cellular Therapy field. He has a special interest in treating Leukaemia, Lymphoma, Myeloma, Stem Cell Transplantation and CAR-T Therapy. He is a Member of the South African Society of Clinical Haematology (SACHaS), the American Society of Haematology (ASH), Chairman of BloodSA, Chairman of the BloodSA Multiple Myeloma Working Group, member of BloodSA Cell and Gene Therapy Working Party and serves on the Executive Committee of the South African Stem Cell Transplant Society (SASCeTS). He also is an Honorary Senior Lecturer in the division of Clinical Haematology at the University of Cape Town. In his spare time, he cycles, runs and rows.
